This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Neuboron Therapy System Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Yi-chiao Teng: Innovator in Radiotherapy Systems
Introduction
Yi-chiao Teng is a notable inventor based in Fujian, China. He has made significant contributions to the field of medical technology, particularly in the development of radiotherapy systems. His innovative approach has led to advancements that enhance the effectiveness of cancer treatment.
Latest Patents
Yi-chiao Teng holds a patent for a radiotherapy system and a therapy plan generation method. This system includes a beam irradiation apparatus, a therapy plan module, and a control module. The beam irradiation apparatus generates a therapeutic beam that irradiates a targeted body area, forming an irradiated part. The therapy plan module contains a tissue model template library of the irradiated body and performs dosage simulation calculations based on medical imaging data and parameters from the beam irradiation apparatus. This process results in the generation of a precise therapy plan. The control module retrieves the therapy plan and directs the beam irradiation apparatus to execute the treatment accordingly.
Career Highlights
Yi-chiao Teng is currently employed at Neuboron Therapy System Ltd., where he continues to innovate in the field of radiotherapy. His work focuses on improving treatment methodologies and enhancing patient outcomes through advanced technology.
Collaborations
He collaborates with talented colleagues, including Jiang Chen and Wei-Lin Chen, who contribute to the development and refinement of radiotherapy systems.
Conclusion
Yi-chiao Teng's contributions to radiotherapy technology exemplify the impact of innovation in medical treatment. His patent and ongoing work at Neuboron Therapy System Ltd. highlight his commitment to improving cancer therapy through advanced systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile